FineTest
Wuhan, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Chinese manufacturer of high-quality ELISA kits, antibodies, and proteins for global life science research.
ImmunologyOncologyInfectious DiseasesNeuroscienceMetabolic DiseasesAutoimmune DiseaseCardiovascular
Technology Platform
Immunoassay development and recombinant protein production platform for manufacturing ELISA kits, antibodies, and proteins, utilizing GMP-standard facilities and multiple expression systems (E. coli, HEK293, CHO).
Opportunities
Growth opportunities include expanding its catalog in high-demand research areas like cell therapy (host residue detection), organoid culture, and infectious disease surveillance, and potentially moving into regulated diagnostic or therapeutic antibody development.
Risk Factors
Key risks include intense competition from larger global reagent suppliers, potential quality perception challenges associated with Chinese manufacturers, reliance on the RUO market which is sensitive to research funding cycles, and intellectual property complexities in antibody production.
Competitive Landscape
Competes with large global reagent companies (e.g., Abcam, Thermo Fisher, Bio-Techne) and Chinese peers (e.g., Sino Biological, ABclonal) by offering a broad, cost-effective product portfolio validated by extensive publication citations and direct manufacturing control.